fingolimod "glenmark" 0,5 mg kapsler, hårde
glenmark pharmaceuticals nordic ab - fingolimodhydrochlorid - kapsler, hårde - 0,5 mg
entyvio
takeda pharma a/s - vedolizumab - colitis, ulcerative; crohn disease - selektive immunosuppressiva - colitis colitisentyvio er indiceret til behandling af voksne patienter med moderat til svær aktiv colitis ulcerosa, der har haft et utilstrækkeligt respons med, tabt svar på, eller var intolerante til enten konventionel behandling eller en tumor nekrose faktor alfa (tnfa) antagonist. crohns diseaseentyvio er indiceret til behandling af voksne patienter med moderat til svær aktiv crohns sygdom, der har haft et utilstrækkeligt respons med, tabt svar på, eller var intolerante til enten konventionel behandling eller en tumor nekrose faktor alfa (tnfa) antagonist. pouchitisentyvio is indicated for the treatment of adult patients with moderately to severely active chronic pouchitis, who have undergone proctocolectomy and ileal pouch anal anastomosis for ulcerative colitis, and have had an inadequate response with or lost response to antibiotic therapy.
dimethyl fumarate mylan
mylan ireland limited - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate "sandoz" 120 mg enterokapsler, hårde
sandoz a/s - dimethylfumarat - enterokapsler, hårde - 120 mg
dimethyl fumarate teva
teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate "hexal" 120 mg enterokapsler, hårde
hexal a/s - dimethylfumarat - enterokapsler, hårde - 120 mg
holoxan 500 mg pulver til injektions-/infusionsvæske, opløsning
baxter a/s - ifosfamid - pulver til injektions-/infusionsvæske, opløsning - 500 mg
sendoxan 50 mg overtrukne tabletter
baxter a/s - cyclophosphamid, vandfrit - overtrukne tabletter - 50 mg